STOCK TITAN
  1. Home
  2. Sec-filings
  3. STAA
  4. [Form 4] STAAR SURGICAL CO Insider Trading Activity

STAAR Surgical (STAA) director Jiang Wei exercises RSUs and receives new grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

STAAR Surgical director Jiang Wei reported equity compensation transactions involving company stock. On June 18, 2026, Jiang Wei exercised 10,683 previously granted restricted stock units into 10,683 shares of common stock, increasing direct common share holdings to 77,127 shares after the transactions.

On the same date, Jiang Wei received a new grant of 6,182 restricted stock units under the annual non-employee director equity compensation program for the 2026-2027 term. These new units are scheduled to vest in full on the earlier of June 18, 2027 or the 2027 Annual Meeting of Shareholders.

Positive

  • None.

Negative

  • None.
Insider Jiang Wei
Role null
Type Security Shares Price Value
Exercise Restricted Stock Units 10,683 $0.00 --
Grant/Award Restricted Stock Units 6,182 $0.00 --
Exercise Common Stock 10,683 $0.00 --
Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 77,127 shares (Direct, null)
Footnotes (1)
  1. Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026. Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.
RSUs exercised 10,683 units Restricted stock units converted to common stock on June 18, 2026
New RSU grant 6,182 units Annual non-employee director equity compensation for 2026-2027 term
Shares held after transactions 77,127 shares Direct common stock holdings following June 18, 2026 exercise
Exercise transactions 1 transaction, 10,683 shares Derivative exercise/conversion reported in transaction summary
Net buy/sell shares 0 shares No open-market buys or sales; neutral net direction
Restricted Stock Units financial
"Reflects restricted stock units granted to the Reporting Person on June 18, 2025..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
annual non-employee director equity compensation program financial
"pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term..."
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Jiang Wei
(Last)(First)(Middle)
25510 COMMERCENTRE DRIVE
(Street)
LAKE FOREST CALIFORNIA 92630
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)06/18/2026M10,683A$077,127D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)$006/18/2026M10,683 (1) (1)Common Stock10,683$00D
Restricted Stock Units(2)$006/18/2026A6,182 (2) (2)Common Stock6,182$06,182D
Explanation of Responses:
1. Reflects restricted stock units granted to the Reporting Person on June 18, 2025, pursuant to the Issuer's annual non-employee director equity compensation program for the 2025-2026 term, which vested on June 18, 2026.
2. Reflects restricted stock units granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.
Remarks:
This Form 4 reflects the equity awards granted to the Reporting Person on June 18, 2026 pursuant to Issuer's annual non-employee director equity compensation program for the 2026-2027 term.
/s/ Kathleen Determann as attorney-in-fact for Jiang Wei06/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Jiang Wei report at STAAR Surgical (STAA)?

Jiang Wei exercised 10,683 restricted stock units into common shares and received a new grant of 6,182 restricted stock units. These actions are part of STAAR Surgical’s non-employee director equity compensation programs for consecutive board terms.

How many STAAR Surgical (STAA) shares does Jiang Wei hold after these transactions?

After the June 18, 2026 transactions, Jiang Wei directly holds 77,127 shares of STAAR Surgical common stock. This figure reflects the exercise of 10,683 restricted stock units into common shares reported in the Form 4 filing.

What is the size and vesting schedule of Jiang Wei’s new RSU grant at STAAR Surgical (STAA)?

Jiang Wei received 6,182 restricted stock units on June 18, 2026. These units vest in full on the earlier of June 18, 2027 or the company’s 2027 Annual Meeting of Shareholders, under the annual non-employee director equity compensation program.

Were Jiang Wei’s STAAR Surgical (STAA) transactions open-market buys or sales?

The reported transactions are equity compensation-related, not open-market buys or sales. They include the exercise of 10,683 previously granted restricted stock units into common stock and a new grant of 6,182 restricted stock units.

Which STAAR Surgical (STAA) director equity programs are referenced in Jiang Wei’s Form 4?

The Form 4 references STAAR Surgical’s annual non-employee director equity compensation programs for the 2025-2026 and 2026-2027 terms. One grant vested on June 18, 2026, and the new grant vests by June 18, 2027 or the 2027 annual meeting.